Michael Lee Ryan
Director at Coherus Oncology, Inc. (CHRS) since July 2023
Michael Lee Ryan has filed 5 insider reports with the SEC since July 2023, as director at Coherus Oncology, Inc. (CHRS). The latest filing, on June 9, 2026, reports grant or award at Coherus Oncology, Inc. (CHRS).
- Filings
- 5
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Michael Lee Ryan is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince July 2023 | 30,000 | $0.3698 | Jun 9, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 5, 2026CHRSDirector Ryan Michael Lee was granted 30,000 sharesForm 4Grant or award
- Jun 12, 2025CHRSSEC Form 4 filed by Director Ryan Michael LeeForm 4Grant or award
- Jun 3, 2024CHRSSEC Form 4 filed by Ryan Michael LeeForm 4Grant or award
- Jul 18, 2023CHRSSEC Form 4 filed by Ryan Michael LeeForm 4Grant or award
- Jul 18, 2023CHRSMichael Lee Ryan became an insiderForm 3New insider
Compare Michael Lee Ryan with
- Michael Lee Ryan vs Ali J. Satvat1 shared
- Michael Lee Ryan vs Rita A Karachun1 shared
- Michael Lee Ryan vs Lee Nisley Newcomer1 shared
- Michael Lee Ryan vs Jill O'Donnell-Tormey1 shared
- Michael Lee Ryan vs Mats Wahlstrom1 shared
- Michael Lee Ryan vs Charles W. Newton1 shared
Other insiders at the same companies
- Ali J. SatvatCHRS
- Rita A KarachunCHRS
- Lee Nisley NewcomerCHRS
- Jill O'Donnell-TormeyCHRS
- Mats WahlstromCHRS
- Charles W. NewtonCHRS
- Bryan J McMichaelCHRS
- Dennis M LanfearCHRS
- Georgia ErbezCHRS
- Paul ReiderCHRS
Questions about Michael Lee Ryan
- What is Michael Lee Ryan's role at Coherus Oncology, Inc.?
- Michael Lee Ryan reports to the SEC as director at Coherus Oncology, Inc. (CHRS), according to the latest filing on June 9, 2026.
- How many shares does Michael Lee Ryan own?
- After the latest filing that states it, Michael Lee Ryan directly owned 30,000 shares of Coherus Oncology, Inc. (CHRS). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Michael Lee Ryan bought or sold stock recently?
- No open-market purchases or sales by Michael Lee Ryan are on file. The filings report grant or award.
- How do I get alerts when Michael Lee Ryan files?
- Follow Michael Lee Ryan on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Michael Lee Ryan (SEC CIK 0001985918). Totals count each trade once, skipping amendments whose original is on file, from Jul 20, 2023 on. View on SEC EDGAR · Get this as JSON